207 research outputs found
The Genetic and Functional Basis of Three Inherited Palmoplantar Keratodermas in Human Disease.
PhD ThesisThe ability of cells to respond to stress is fundamental for survival. The palmoplantar
epidermis, by its very nature, is subjected to substantial external forces. At birth, the skin at
these sites is similar to the skin elsewhere, however, as we expose it to physical stresses such
as walking and gripping, it thickens to adapt. The palmoplantar keratodermas (PPKs) are a
heterogeneous group of disorders characterised by abnormal thickening of the palmoplantar
epidermis. Causative mutations have been identified in a diverse array of genes, such as
those encoding the TNFα sheddase, ADAM17, and the water channel protein, Aquaporin 5.
Three distinct PPK’s were studied in order to unravel the molecular basis of their associated
diseases. The work presented here identifies the palmoplantar and stress-associated Keratin
16 as a novel interacting protein for iRHOM2, and demonstrates that this regulatory
relationship contributes to palmoplantar thickness in Tylosis with Oesophageal Cancer. The
deep clinical phenotyping of patients with ARVC caused by dominantly inherited mutations
in desmoplakin revealed an unreported cutaneous phenotype of PPK and curly hair which
may prove useful in the diagnosis of this complex disease. Finally, this Thesis includes the
discovery of the first human disease-causing mutation in FAM83G, which presented with a
unique phenotype of PPK and abundant curly hair and linked FAM83G to Wnt signaling. By
correlating the clinical phenotype with the genotype in each case, and extrapolating from
rare monogenic diseases to more common disorders, the PPK’s provide a unique resource in
which to study the genetic basis of disease
Comparative safety and efficacy of vasopressors for mortality in septic shock: A network meta-analysis
© 2015, © The Intensive Care Society 2015.Introduction: Septic shock is a life-threatening condition requiring vasopressor agents to support the circulatory system. Several agents exist with choice typically guided by the specific clinical scenario. We used a network meta-analysis approach to rate the comparative efficacy and safety of vasopressors for mortality and arrhythmia incidence in septic shock patients. Methods: We performed a comprehensive electronic database search including Medline, Embase, Science Citation Index Expanded and the Cochrane database. Randomised trials investigating vasopressor agents in septic shock patients and specifically assessing 28-day mortality or arrhythmia incidence were included. A Bayesian network meta-analysis was performed using Markov chain Monte Carlo methods. Results: Thirteen trials of low to moderate risk of bias in which 3146 patients were randomised were included. There was no pairwise evidence to suggest one agent was superior over another for mortality. In the network meta-analysis, vasopressin was significantly superior to dopamine (OR 0.68 (95% CI 0.5 to 0.94)) for mortality. For arrhythmia incidence, standard pairwise meta-analyses confirmed that dopamine led to a higher incidence of arrhythmias than norepinephrine (OR 2.69 (95% CI 2.08 to 3.47)). In the network meta-analysis, there was no evidence of superiority of one agent over another. Conclusions: In this network meta-analysis, vasopressin was superior to dopamine for 28-day mortality in septic shock. Existing pairwise information supports the use of norepinephrine over dopamine. Our findings suggest that dopamine should be avoided in patients with septic shock and that other vasopressor agents should continue to be based on existing guidelines and clinical judgement of the specific presentation of the patient
Knowledge of Driving Vehicle Licensing Agency guidelines among NHS doctors:A multicentre observational study
Objectives: Over half of the UK population holds a driver's licence. The DVLA have produced guidelines to ensure drivers with medical conditions drive safely. Doctors should ensure that patients are given appropriate information and advice if they have a medical condition affecting their driving. We sought to evaluate doctors' knowledge of DVLA guidelines. Design: A 25-point questionnaire was designed from DVLA guidelines (‘The DVLA Questionnaire’). Five questions were included for each of neurology, cardiology, drug and alcohol abuse, visual, and respiratory disorders. Setting: Ealing Hospital, Northwick Park Hospital, Watford General Hospital, Norfolk and Norwich University Hospital and Leeds Teaching Hospitals Trust. Participants: 140 UK doctors. Main outcome measures: Questionnaire scores assessing knowledge of DVLA guidelines in five specialty areas. Results: The median overall questionnaire score was 28%, interquartile range 20–36% and range 0–100% [Watford 28%, Leeds 30%, Norfolk and Norwich 36%, Ealing 30%, Northwick Park 28%]. There were no significant differences between the scores for each centre (p = 0.1332), Mean scores for specialty areas were: neurology 33.1%, standard deviation 22.1; cardiology 35.6%, standard deviation 26.9; drug and alcohol abuse 30.6%, standard deviation 23.8; visual disorders 33.9%, standard deviation 23.5 and respiratory disorders 20.3%, standard deviation 24.8; overall score 30.7%. There was no significant difference between the scores of the specialty areas (p = 0.4060). Conclusions: Knowledge of DVLA guidelines in our cohort was low. There is a need for increased awareness among hospital doctors through focused education on driving restrictions for common medical conditions. Improving physician knowledge in this area may help optimise patient safety
Trends in Mortality from Ischaemic Heart Disease and Cerebrovascular Disease in Europe: 1980-2009.
Recommended from our members
Patient- and surgeon-adjusted control charts for monitoring performance
Objectives: To determine whether an innovative graphical tool for accurate measurement of individual surgeon performance metrics, adjusted for both surgeon-specific and patient-specific factors, significantly alters interpretation of performance data. Design: Retrospective analysis of all total knee replacements (TKRs) conducted at the host institution between 1996 and 2009. The database was randomly divided into training and testing datasets. Using multivariate generalised estimating equation regression models, the training dataset enabled generation of patient-risk and surgeon-experience adjustment factors. To simulate prospective monitoring of individual surgeon outcomes, the testing dataset was mapped on control charts. Weighted κ statistics were calculated to measure the agreement between patient-risk adjusted and fully adjusted control charts. Setting: Tertiary care academic hospital. Participants: All patients undergoing TKR at the host institution 1996–2009. Main outcome measure Operative efficiency. Results: 5313 procedures were analysed. Adjusted control charts were generated using a training dataset comprising 3756 procedures performed by 13 surgeons. The operative time gradually declined by 121 min with 25 years of experience (p<0.0001). Charts were tested by monitoring four other surgeons, performing an average of 389 procedures each. Adjustment for surgeon experience significantly altered the interpretation of operative efficiency (κ=0.29 (95% CI 0.11 to 0.47)), and enhanced assessment of a surgeon's improvement or diminishment in efficiency over time. Specifically, experience adjustment inverted the interpretation of surgeon efficiency from above average to below average, or from improving to declining performance. Conclusions: Adjustment for surgeon experience is necessary for accurate interpretation of metrics over the course of a surgeon's career. Patient-adjusted and surgeon-adjusted control charts provide an accurate method of monitoring individual operative efficiency
Clinical and genetic studies reveal cutaneous phenotypes linked to desmoplakin haploinsufficiency in arrhythmogenic cardiomyopathy
Tylosis with oesophageal cancer: Diagnosis, management and molecular mechanisms
Research on iRHOM2 in the Kelsell group is funded by an MRC project grant,
a MRC Clinical Fellowship (to TM) and a Cancer Research UK program grant
- …